ArticleJAMA2017

Cetuximab or Bevacizumab With First-Line Chemotherapy in Advanced KRAS Wild-Type Colorectal Cancer: No Difference, but Not the Same.

Christopher H Lieu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.